The global genomics industry is entering a new era driven by the growing demand for highly accurate long-read sequencing technologies. Among the most transformative innovations in this space is Single-Molecule Real-Time (SMRT) sequencing, a technology that is reshaping genomic research, precision medicine, cancer diagnostics, and complex disease analysis.

The global Single-Molecule Real-Time (SMRT) sequencing market is projected to grow from USD 2.92 billion in 2025 to USD 5.32 billion by 2030, registering a strong CAGR of 12.8% during the forecast period. The market’s rapid expansion is fueled by increasing demand for long and highly accurate genomic reads, rising investments in population genomics projects, growing applications in rare disease research, and expanding adoption in epigenetics and transcriptomics studies.

Understanding the Growing Importance of SMRT Sequencing

Traditional short-read sequencing technologies have transformed genomics over the past decade, but they often struggle to resolve highly repetitive or structurally complex genomic regions. SMRT sequencing addresses these limitations by delivering long, high-fidelity (HiFi) reads capable of detecting structural variants, repeat expansions, haplotype phasing, and full-length transcripts with exceptional accuracy.

This capability has become increasingly critical in applications such as cancer genomics, rare disease analysis, neurological disorder research, and de novo genome assembly. Researchers and clinicians are turning to long-read sequencing technologies to gain deeper genomic insights that are often missed by conventional short-read platforms.

As genomic medicine continues evolving toward personalized healthcare, the ability of SMRT sequencing to provide comprehensive and accurate genomic information is positioning the technology as a major driver of next-generation precision medicine.

Rising Demand for Long-Read Sequencing Accelerating Market Growth

One of the primary factors fueling the SMRT sequencing market is the increasing need for long-read sequencing in complex genomic studies.

Rare diseases and cancer genomics often involve structural variations and repeat regions that are difficult to identify using short-read sequencing methods. SMRT sequencing enables researchers to capture these genomic complexities with fewer assembly gaps and improved variant detection accuracy.

The growing focus on precision oncology is also contributing to market growth. Long-read sequencing technologies allow researchers to identify tumor heterogeneity, complex gene fusions, and epigenetic modifications that can influence treatment decisions and therapeutic outcomes.

Additionally, the expansion of large-scale population genomics initiatives and national sequencing programs is driving adoption of advanced sequencing technologies worldwide. Governments, research institutes, and biotechnology organizations are increasingly investing in genomic infrastructure to support disease prevention, early diagnosis, and personalized medicine initiatives.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=161993235 

Products Segment Dominated the Market in 2024

Based on offering, the SMRT sequencing market is segmented into products and services. In 2024, the products segment accounted for the dominant market share.

The rapid growth of installed SMRT sequencing systems across genome centers, academic institutions, specialty laboratories, and sequencing service providers is sustaining strong demand for consumables and reagents. Products such as SMRT Cells, sequencing reagent kits, polymerase kits, binding kits, and library preparation kits are essential for every sequencing run and represent a recurring revenue stream for market players.

These products are particularly valuable because they enable high-accuracy HiFi reads required for advanced genomic applications, including structural variant analysis, haplotype phasing, full-length transcript sequencing, and epigenetic profiling.

As sequencing throughput and adoption continue increasing globally, demand for sequencing consumables and workflow products is expected to remain strong throughout the forecast period.

Academic and Research Institutes Lead End-User Adoption

Academic and research institutes represented the largest end-user segment in 2024, reflecting the strong adoption of SMRT sequencing technologies in universities, genome centers, and core research facilities.

Research institutions extensively use long-read sequencing technologies for de novo genome assembly, functional genomics, transcriptomics, structural variant mapping, and repeat expansion studies. SMRT sequencing is also playing a critical role in advancing full-length RNA sequencing applications such as Iso-Seq, which enables researchers to study transcript diversity with exceptional precision.

The increasing number of genomics research projects, collaborative sequencing initiatives, and method development programs is further accelerating adoption across academic environments.

Additionally, growing government support for genomics research and precision medicine programs is helping academic institutions expand their sequencing capabilities and infrastructure.

Expanding Applications in Drug Discovery and Clinical Diagnostics

SMRT sequencing is increasingly being integrated into drug discovery and clinical diagnostics workflows due to its ability to generate highly accurate genomic insights.

In drug discovery, pharmaceutical and biotechnology companies are leveraging long-read sequencing to identify novel therapeutic targets, understand disease mechanisms, and improve biomarker discovery. The technology is particularly useful for analyzing highly complex genomic regions associated with genetic disorders and cancer progression.

Clinical diagnostic applications are also growing rapidly, especially in rare disease testing and oncology research. Long-read sequencing improves detection of clinically relevant structural variants and repeat expansions that may remain undetected using conventional sequencing methods.

Furthermore, SMRT sequencing is gaining significant traction in epigenetic studies because it enables direct detection of DNA modifications without requiring additional sample processing steps.

Asia Pacific Emerging as the Fastest-Growing Regional Market

Asia Pacific is expected to witness the highest CAGR in the SMRT sequencing market during the forecast period.

The region is experiencing rapid growth in genomics research investments, biotechnology development, and healthcare modernization initiatives. Countries such as China, Japan, India, South Korea, and Singapore are investing heavily in genome centers, advanced research laboratories, and precision medicine programs.

The increasing adoption of long-read sequencing technologies in cancer research, rare disease testing, translational medicine, and agricultural genomics is driving regional market expansion.

Government-backed genomic initiatives and growing collaborations between academic institutions, healthcare organizations, and biotechnology companies are also strengthening the regional ecosystem for advanced sequencing technologies.

As awareness regarding the clinical value of long-read sequencing continues increasing, Asia Pacific is expected to become a major growth engine for the global SMRT sequencing industry.

Competitive Landscape and Technological Innovation

The SMRT sequencing market is characterized by rapid technological innovation and increasing competition among leading genomics companies.

Prominent market players include Illumina, Inc., Thermo Fisher Scientific Inc., PacBio, and Agilent Technologies, Inc. These companies are actively investing in next-generation sequencing platforms, workflow automation, reagent development, and advanced bioinformatics solutions.

Technology providers are also focusing on improving sequencing throughput, reducing turnaround time, enhancing read accuracy, and lowering overall sequencing costs to expand adoption across clinical and research settings.

Strategic collaborations, acquisitions, and partnerships with research institutions and healthcare organizations are further shaping the competitive landscape of the market.

Future Outlook for the SMRT Sequencing Market

The future of the SMRT sequencing market looks highly promising as genomics continues moving toward comprehensive long-read analysis and precision medicine applications.

The increasing demand for accurate structural variant detection, full-length transcript sequencing, epigenetic profiling, and population genomics research will continue driving market growth over the next decade.

Emerging applications in personalized medicine, oncology, reproductive health, and agricultural genomics are expected to further broaden the adoption of SMRT sequencing technologies worldwide.

As sequencing technologies become more accessible and cost-effective, SMRT sequencing is poised to become an essential tool for advancing genomic research, accelerating drug discovery, and enabling more precise and personalized healthcare solutions.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=161993235